$42.16
-0.23 (-0.54%)
Cepheid (NASDAQ:CPHD)
CAPS Rating:
A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets.
RSS Headlines
Fool UK